|
SG11201600853UA
(en)
|
2013-08-05 |
2016-03-30 |
Twist Bioscience Corp |
De novo synthesized gene libraries
|
|
US10669304B2
(en)
|
2015-02-04 |
2020-06-02 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
US9981239B2
(en)
|
2015-04-21 |
2018-05-29 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
EP3350314A4
(en)
|
2015-09-18 |
2019-02-06 |
Twist Bioscience Corporation |
OLIGONUCLEIC ACID VARIANT LIBRARIES VARIANT AND SYNTHESIS THEREOF
|
|
KR102794025B1
(ko)
|
2015-09-22 |
2025-04-09 |
트위스트 바이오사이언스 코포레이션 |
핵산 합성을 위한 가요성 기판
|
|
CN115920796A
(zh)
|
2015-12-01 |
2023-04-07 |
特韦斯特生物科学公司 |
功能化表面及其制备
|
|
CN116731156A
(zh)
*
|
2016-03-16 |
2023-09-12 |
伊玛提克斯生物技术有限公司 |
用于癌症免疫治疗的转染t细胞和t细胞受体
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
EP3500672A4
(en)
|
2016-08-22 |
2020-05-20 |
Twist Bioscience Corporation |
DE NOVO SYNTHETIZED NUCLEIC ACID LIBRARIES
|
|
US10417457B2
(en)
|
2016-09-21 |
2019-09-17 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
|
KR20240007775A
(ko)
|
2016-12-08 |
2024-01-16 |
이매틱스 바이오테크놀로지스 게엠베하 |
T 세포 수용체 및 이를 사용하는 면역 요법
|
|
DE102016123847B3
(de)
*
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
GB2573069A
(en)
*
|
2016-12-16 |
2019-10-23 |
Twist Bioscience Corp |
Variant libraries of the immunological synapse and synthesis thereof
|
|
EP4556433A3
(en)
|
2017-02-22 |
2025-08-06 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
|
WO2018170169A1
(en)
|
2017-03-15 |
2018-09-20 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
|
BR112019020959A2
(pt)
*
|
2017-04-10 |
2020-05-05 |
Immatics Biotechnologies Gmbh |
peptídeos e combinações dos mesmos para uso na imunoterapia contra câncer
|
|
WO2018231872A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
US11407837B2
(en)
|
2017-09-11 |
2022-08-09 |
Twist Bioscience Corporation |
GPCR binding proteins and synthesis thereof
|
|
EP3691662A4
(en)
*
|
2017-10-06 |
2021-05-12 |
The University of Chicago |
SCREENING OF T LYMPHOCYTE FOR CANCER SPECIFIC ANTIGENS
|
|
JP2021500878A
(ja)
|
2017-10-12 |
2021-01-14 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
免疫療法のためのｔ細胞受容体
|
|
CN111565834B
(zh)
|
2017-10-20 |
2022-08-26 |
特韦斯特生物科学公司 |
用于多核苷酸合成的加热的纳米孔
|
|
KR102804057B1
(ko)
|
2018-01-04 |
2025-05-07 |
트위스트 바이오사이언스 코포레이션 |
Dna 기반 디지털 정보 저장
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
WO2019196088A1
(en)
|
2018-04-13 |
2019-10-17 |
Syz Cell Therapy Co. |
Methods of obtaining tumor-specific t cell receptors
|
|
CA3100739A1
(en)
|
2018-05-18 |
2019-11-21 |
Twist Bioscience Corporation |
Polynucleotides, reagents, and methods for nucleic acid hybridization
|
|
WO2020049496A1
(en)
*
|
2018-09-05 |
2020-03-12 |
Glaxosmithkline Intellectual Property Development Limited |
T cell modification
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
MA53599A
(fr)
*
|
2018-09-14 |
2021-07-21 |
Immatics Biotechnologies Gmbh |
Procédé de criblage par affinité peptide-cmh à haut débit destiné à des ligands de tcr
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
WO2020139871A1
(en)
|
2018-12-26 |
2020-07-02 |
Twist Bioscience Corporation |
Highly accurate de novo polynucleotide synthesis
|
|
JP2022522668A
(ja)
|
2019-02-26 |
2022-04-20 |
ツイスト バイオサイエンス コーポレーション |
抗体を最適化するための変異体核酸ライブラリ
|
|
CN113766930B
(zh)
|
2019-02-26 |
2025-07-22 |
特韦斯特生物科学公司 |
Glp1受体的变异核酸文库
|
|
DE102019108125B4
(de)
|
2019-03-28 |
2022-02-03 |
Immatics US, Inc. |
Cd28 t-zellkulturen, zusammensetzungen und verfahren zu deren verwendung
|
|
US20200297768A1
(en)
|
2019-03-19 |
2020-09-24 |
Immatics US, Inc. |
Cd28 t cell cultures, compositions, and methods of using thereof
|
|
EP3714941A1
(en)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
CN111748028A
(zh)
*
|
2019-03-29 |
2020-10-09 |
天津亨佳生物科技发展有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CN111748029B
(zh)
*
|
2019-03-29 |
2022-12-13 |
苏州蓝马医疗技术有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CA3139011A1
(en)
|
2019-05-08 |
2020-11-12 |
Medigene Immunotherapies Gmbh |
Engineered t cells
|
|
WO2020243134A1
(en)
|
2019-05-27 |
2020-12-03 |
Immatics US, Inc. |
Viral vectors and their use in adoptive cellular therapy
|
|
PH12021553152A1
(en)
*
|
2019-06-18 |
2022-08-15 |
Regeneron Pharma |
Mage-a4 t cell receptors and methods of use thereof
|
|
CA3144054A1
(en)
*
|
2019-06-20 |
2020-12-24 |
Memorial Sloan-Kettering Cancer Center |
T cell receptors targeting pik3ca mutations and uses thereof
|
|
US11332738B2
(en)
|
2019-06-21 |
2022-05-17 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
|
CN110357953B
(zh)
*
|
2019-07-17 |
2022-05-03 |
深圳市因诺转化医学研究院 |
识别人巨细胞病毒pp65抗原的TCR
|
|
CN114502580B
(zh)
*
|
2019-07-30 |
2025-10-17 |
大学健康网络 |
Mhc ii类分子及其使用方法
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
DE102019121007A1
(de)
*
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
EP4034566A4
(en)
|
2019-09-23 |
2024-01-24 |
Twist Bioscience Corporation |
VARIANT NUCLEIC ACID BANKS FOR CRTH2
|
|
JP2022548783A
(ja)
|
2019-09-23 |
2022-11-21 |
ツイスト バイオサイエンス コーポレーション |
単一ドメイン抗体のバリアント核酸ライブラリー
|
|
BR112022011235A2
(pt)
|
2019-12-09 |
2022-12-13 |
Twist Bioscience Corp |
Bibliotecas de variantes de ácido nucleico para receptores de adenosina
|
|
EP4087594A4
(en)
*
|
2020-01-06 |
2024-02-28 |
Memorial Sloan Kettering Cancer Center |
Novel dominant negative fas polypeptides, cells comprising thereof and uses thereof
|
|
CA3168729A1
(en)
|
2020-02-24 |
2021-09-02 |
Melinda MATA |
Methods for expanding t cells for the treatment of cancer and related malignancies
|
|
DE102020111571A1
(de)
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
CN113621070A
(zh)
*
|
2020-05-06 |
2021-11-09 |
华夏英泰（北京）生物技术有限公司 |
一种t细胞抗原受体、其多聚体复合物及其制备方法和应用
|
|
US20220056411A1
(en)
|
2020-08-21 |
2022-02-24 |
Immatics US, Inc. |
Methods for isolating cd8+ selected t cells
|
|
CN116457371A
(zh)
*
|
2020-10-07 |
2023-07-18 |
多安生物治疗有限公司 |
T细胞受体、包含t细胞受体的免疫细胞及其使用方法
|
|
DE102021100038A1
(de)
|
2020-12-31 |
2022-06-30 |
Immatics US, Inc. |
Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung
|
|
TW202241938A
(zh)
|
2020-12-31 |
2022-11-01 |
美商英麥提克斯股份有限公司 |
Ｃｄ８多肽、組合物及其使用方法
|
|
CN115975003B
(zh)
*
|
2021-03-09 |
2024-01-26 |
科士华(南京)生物技术有限公司 |
Tcr、多肽、表达载体、宿主细胞、药物组合物和tcr获得方法
|
|
AU2022241654A1
(en)
*
|
2021-03-22 |
2023-09-28 |
Juno Therapeutics, Inc. |
Methods of determining potency of a therapeutic cell composition
|
|
US20240190940A1
(en)
*
|
2021-04-21 |
2024-06-13 |
The United States of America, as represented by the Secretary, Department of Health and Human Serice |
Hla class i-restricted t cell receptors against ras with q61k mutation
|
|
IL308258A
(en)
|
2021-05-05 |
2024-01-01 |
Immatics Biotechnologies Gmbh |
Bma031 antigen binding polypeptides
|
|
CN113337514B
(zh)
*
|
2021-08-05 |
2021-10-29 |
卡瑞济(北京)生命科技有限公司 |
Tcr表达构建体以及其制备方法和用途
|
|
TW202332765A
(zh)
|
2021-09-20 |
2023-08-16 |
美商英麥提克斯股份有限公司 |
用於ｔ細胞療法之ｔ細胞群體的單核球耗盡
|
|
CN113773378B
(zh)
*
|
2021-10-14 |
2023-11-03 |
深圳大学总医院 |
T细胞受体及其应用
|
|
KR20240091226A
(ko)
*
|
2021-11-03 |
2024-06-21 |
큐론 바이오파마슈티칼 (상하이) 컴퍼니, 리미티드 |
신규 항 l1cam 항체
|
|
US20230142468A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics US, Inc. |
Methods for generating cell spheroids
|
|
EP4448108A1
(en)
|
2021-11-08 |
2024-10-23 |
Immatics Biotechnologies GmbH |
Adoptive cell therapy combination treatment and compositions thereof
|
|
US20250134999A1
(en)
|
2022-01-14 |
2025-05-01 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene activation
|
|
US20250154503A1
(en)
|
2022-01-14 |
2025-05-15 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene repression
|
|
EP4472742A1
(en)
*
|
2022-02-03 |
2024-12-11 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
WO2023183758A2
(en)
*
|
2022-03-19 |
2023-09-28 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules targeting cd3 and mage-a4 and uses thereof
|
|
US20230348561A1
(en)
|
2022-04-28 |
2023-11-02 |
Immatics US, Inc. |
Dominant negative tgfbeta receptor polypeptides, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
EP4514821A1
(en)
|
2022-04-28 |
2025-03-05 |
Immatics US, Inc. |
Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof
|
|
EP4514829A1
(en)
|
2022-04-28 |
2025-03-05 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2023215825A1
(en)
|
2022-05-05 |
2023-11-09 |
Immatics US, Inc. |
Methods for improving t cell efficacy
|
|
JP2025525382A
(ja)
*
|
2022-06-24 |
2025-08-05 |
アムジエン・インコーポレーテツド |
Ｍａｇｅａ４特異的ｔ細胞受容体
|
|
WO2024036166A1
(en)
*
|
2022-08-08 |
2024-02-15 |
The University Of North Carolina At Chapel Hill |
Bioorthogonal t cell receptor molecules and methods of making and using the same
|
|
WO2024064642A2
(en)
|
2022-09-19 |
2024-03-28 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for modulating t cell function
|
|
CN121909284A
(zh)
|
2023-07-31 |
2026-04-21 |
图恩疗法股份有限公司 |
用于调节il-2基因表达的组合物和方法
|
|
WO2025029840A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for multiplexed activation and repression of t cell gene expression
|
|
WO2025096649A1
(en)
|
2023-11-01 |
2025-05-08 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2025233432A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Use and dosage of an antigen-binding protein comprising a tcr specific for an hla-a*02 restricted peptide
|
|
WO2026008886A1
(en)
|
2024-07-05 |
2026-01-08 |
Immatics Biotechnologies Gmbh |
Means and methods for the quantification of target expression
|
|
WO2026082746A1
(en)
|
2024-10-14 |
2026-04-23 |
Immatics Biotechnologies Gmbh |
Bispecific molecule formulation
|